Cyprus
Apollon I Ne is a company focused on developing needle-free continuous glucose monitoring technology. Their prototype, MOGLU®, has demonstrated accuracy comparable to leading CGMs in IRB-approved trials with MIT. The company's device uses Raman spectroscopy and targets specific wavelengths to enhance sensitivity while maintaining compactness. Apollon has received clinical validation through Clarke Error Grid analysis, where all 279 data points fell within Zone A or B. The company is headquartered in Boston, USA, and has a presence in Seoul, Korea. Founded in 2025, Apollon has built an elite advisory board ahead of its FDA De Novo program, adding a Harvard CGM leader and a BCG veteran to its team.
Browsing, company names, locations and sectors are always free. A free account adds 5 contact releases every month — e-mail and phone, view or export. Need more? Contact packs start at 19 € for 50, or upgrade to a monthly plan.
Yes — no card required. Browsing is always free, and a free account adds 5 contact releases every month.
Your first 5 contact releases each month are included in the free account. After that, packs start at 19 € for 50 contacts (view or export), or a monthly plan for regular use.
Companies are harvested from the open web — registers, websites and industry directories — not self-registered sign-ups. Contact details are shown only once you use a release or credit, never invented.